Home / Sources / Select Committees / Drugs policy: medicinal cannabis: Government Response to th…
Select committee: Health and Social Care Committee

Drugs policy: medicinal cannabis: Government Response to the Committee's Sixteenth Report

Published 6 September 2019

Health and Social Care Committee Drugs policy: medicinal cannabis inquiry Report on parliament.uk ↗

At a glance

The government's response

This document responds to 16th Report - Drugs policy: medicinal cannabis.

This is the government's response, published 6 September 2019.

Summary written by Accountability Index from the government's response. It is not the government's own words.

The government's response sets out actions on communications, research, guidance and supply, and states that more research is required on clinical and cost effectiveness "before decisions on public funding can be made".

  • On communications, it is "committed" to actions including expanded Gov.uk and NHS.uk information, and NHSE-I and DHSC "will work together to develop clear information for patients and patient groups"; it will "explore" using the Science and Media Centre.
  • On research, NIHR has issued two calls; any successful applications from the second call "would be expected to start around Autumn 2020", and NIHR funding "is not ring-fenced".
  • On guidance, NICE will "carefully consider all responses" to its draft guidelines "with a view to publishing final guidelines in November 2019"; HEE e-learning is intended to be updated "on at least a quarterly basis".
  • On supply, it says "further work on establishing a stable UK supply will be undertaken", including scoping options for UK manufacturers.

Read the government's response ↗ Report an error

Sources